These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 26415756)

  • 1. A novel delivery platform based on Bacteriophage MS2 virus-like particles.
    Fu Y; Li J
    Virus Res; 2016 Jan; 211():9-16. PubMed ID: 26415756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual Surface Modification of Genome-Free MS2 Capsids for Delivery Applications.
    Aanei IL; Francis MB
    Methods Mol Biol; 2018; 1776():629-642. PubMed ID: 29869270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production in Saccharomycescerevisiae of MS2 virus-like particles packaging functional heterologous mRNAs.
    Legendre D; Fastrez J
    J Biotechnol; 2005 May; 117(2):183-94. PubMed ID: 15823407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a microRNA delivery system based on bacteriophage MS2 virus-like particles.
    Pan Y; Zhang Y; Jia T; Zhang K; Li J; Wang L
    FEBS J; 2012 Apr; 279(7):1198-208. PubMed ID: 22309233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MS2 viruslike particles: a robust, semisynthetic targeted drug delivery platform.
    Galaway FA; Stockley PG
    Mol Pharm; 2013 Jan; 10(1):59-68. PubMed ID: 23110441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Selection for Assembly Reveals That a Single Amino Acid Mutant of the Bacteriophage MS2 Coat Protein Forms a Smaller Virus-like Particle.
    Asensio MA; Morella NM; Jakobson CM; Hartman EC; Glasgow JE; Sankaran B; Zwart PH; Tullman-Ercek D
    Nano Lett; 2016 Sep; 16(9):5944-50. PubMed ID: 27549001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new RNA vaccine platform based on MS2 virus-like particles produced in Saccharomyces cerevisiae.
    Sun S; Li W; Sun Y; Pan Y; Li J
    Biochem Biophys Res Commun; 2011 Apr; 407(1):124-8. PubMed ID: 21362402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-specific delivery of diverse cargos by bacteriophage MS2 virus-like particles.
    Ashley CE; Carnes EC; Phillips GK; Durfee PN; Buley MD; Lino CA; Padilla DP; Phillips B; Carter MB; Willman CL; Brinker CJ; Caldeira Jdo C; Chackerian B; Wharton W; Peabody DS
    ACS Nano; 2011 Jul; 5(7):5729-45. PubMed ID: 21615170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deciphering the Thermal Stability of Bacteriophage MS2-Derived Virus-like Particle and Its Engineered Variant.
    Vishwakarma P; Puri S; Banerjee M; Chang CY; Chang CC; Chaudhuri TK
    ACS Biomater Sci Eng; 2024 Aug; 10(8):4812-4822. PubMed ID: 38976823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Messenger RNA vaccine based on recombinant MS2 virus-like particles against prostate cancer.
    Li J; Sun Y; Jia T; Zhang R; Zhang K; Wang L
    Int J Cancer; 2014 Apr; 134(7):1683-94. PubMed ID: 24105486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurements of the self-assembly kinetics of individual viral capsids around their RNA genome.
    Garmann RF; Goldfain AM; Manoharan VN
    Proc Natl Acad Sci U S A; 2019 Nov; 116(45):22485-22490. PubMed ID: 31570619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing the synthesis and purification of MS2 virus like particles.
    Hashemi K; Ghahramani Seno MM; Ahmadian MR; Malaekeh-Nikouei B; Bassami MR; Dehghani H; Afkhami-Goli A
    Sci Rep; 2021 Oct; 11(1):19851. PubMed ID: 34615923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The structure of bacteriophage phiCb5 reveals a role of the RNA genome and metal ions in particle stability and assembly.
    Plevka P; Kazaks A; Voronkova T; Kotelovica S; Dishlers A; Liljas L; Tars K
    J Mol Biol; 2009 Aug; 391(3):635-47. PubMed ID: 19559027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of coat-protein concentration on the self-assembly of bacteriophage MS2 capsids around RNA.
    Williams LA; Neophytou A; Garmann RF; Chakrabarti D; Manoharan VN
    Nanoscale; 2024 Feb; 16(6):3121-3132. PubMed ID: 38258446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virus-like particles derived from bacteriophage MS2 as antigen scaffolds and RNA protective shells.
    Naskalska A; Heddle JG
    Nanomedicine (Lond); 2024; 19(12):1103-1115. PubMed ID: 38629576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenic display of diverse peptides on virus-like particles of RNA phage MS2.
    Peabody DS; Manifold-Wheeler B; Medford A; Jordan SK; do Carmo Caldeira J; Chackerian B
    J Mol Biol; 2008 Jun; 380(1):252-63. PubMed ID: 18508079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel miR-122 delivery system based on MS2 virus like particle surface displaying cell-penetrating peptide TAT for hepatocellular carcinoma.
    Wang G; Jia T; Xu X; Chang L; Zhang R; Fu Y; Li Y; Yang X; Zhang K; Lin G; Han Y; Li J
    Oncotarget; 2016 Sep; 7(37):59402-59416. PubMed ID: 27449085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of phage MS2 coat protein mutants expressed from a reconstituted phagemid reveals that proline 78 is essential for viral infectivity.
    Hill HR; Stonehouse NJ; Fonseca SA; Stockley PG
    J Mol Biol; 1997 Feb; 266(1):1-7. PubMed ID: 9054964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The MS2 coat protein shell is likely assembled under tension: a novel role for the MS2 bacteriophage A protein as revealed by small-angle neutron scattering.
    Kuzmanovic DA; Elashvili I; Wick C; O'Connell C; Krueger S
    J Mol Biol; 2006 Feb; 355(5):1095-111. PubMed ID: 16359706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA bacteriophage capsid-mediated drug delivery and epitope presentation.
    Brown WL; Mastico RA; Wu M; Heal KG; Adams CJ; Murray JB; Simpson JC; Lord JM; Taylor-Robinson AW; Stockley PG
    Intervirology; 2002; 45(4-6):371-80. PubMed ID: 12602361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.